CV3- VASOPEPTIDASE INHIBITOR REDUCES IN-HOSPITAL COSTS FOR CONGESTIVE HEART FAILURE PATIENTS- RESULTS FROM THE IMPRESS TRIAL
Abstract
Authors
EL Eisenstein CL Nelson TA Simon AL Smitten P Lapuerta DB Mark
EL Eisenstein CL Nelson TA Simon AL Smitten P Lapuerta DB Mark
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now